Exploring mortality among drug treatment clients: The relationship between treatment type and mortality
© 2017 Aims Studies consistently identify substance treatment populations as more likely to die prematurely compared with age-matched general population, with mortality risk higher out-of-treatment than in-treatment. While opioid-using pharmacotherapy cohorts have been studied extensively, less evid...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/57697 |
| _version_ | 1848760072751022080 |
|---|---|
| author | Lloyd, B. Zahnow, R. Barratt, Monica Best, D. Lubman, D. Ferris, J. |
| author_facet | Lloyd, B. Zahnow, R. Barratt, Monica Best, D. Lubman, D. Ferris, J. |
| author_sort | Lloyd, B. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | © 2017 Aims Studies consistently identify substance treatment populations as more likely to die prematurely compared with age-matched general population, with mortality risk higher out-of-treatment than in-treatment. While opioid-using pharmacotherapy cohorts have been studied extensively, less evidence exists regarding effects of other treatment types, and clients in treatment for other drugs. This paper examines mortality during and following treatment across treatment modalities. Methods A retrospective seven-year cohort was utilised to examine mortality during and in the two years following treatment among clients from Victoria, Australia, recorded on the Alcohol and Drug Information Service database by linking with National Death Index. 18,686 clients over a 12-month period were included. Crude (CMRs) and standardised mortality rates (SMRs) were analysed in terms of treatment modality, and time in or out of treatment. Results Higher risk of premature death was associated with residential withdrawal as the last type of treatment engagement, while mortality following counselling was significantly lower than all other treatment types in the year post-treatment. Both CMRs and SMRs were significantly higher in-treatment than post-treatment. Conclusion Better understanding of factors contributing to elevated mortality risk for clients engaged in, and following treatment, is needed to ensure that treatment systems provide optimal outcomes during and after treatment. |
| first_indexed | 2025-11-14T10:09:58Z |
| format | Journal Article |
| id | curtin-20.500.11937-57697 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T10:09:58Z |
| publishDate | 2017 |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-576972017-11-20T08:58:16Z Exploring mortality among drug treatment clients: The relationship between treatment type and mortality Lloyd, B. Zahnow, R. Barratt, Monica Best, D. Lubman, D. Ferris, J. © 2017 Aims Studies consistently identify substance treatment populations as more likely to die prematurely compared with age-matched general population, with mortality risk higher out-of-treatment than in-treatment. While opioid-using pharmacotherapy cohorts have been studied extensively, less evidence exists regarding effects of other treatment types, and clients in treatment for other drugs. This paper examines mortality during and following treatment across treatment modalities. Methods A retrospective seven-year cohort was utilised to examine mortality during and in the two years following treatment among clients from Victoria, Australia, recorded on the Alcohol and Drug Information Service database by linking with National Death Index. 18,686 clients over a 12-month period were included. Crude (CMRs) and standardised mortality rates (SMRs) were analysed in terms of treatment modality, and time in or out of treatment. Results Higher risk of premature death was associated with residential withdrawal as the last type of treatment engagement, while mortality following counselling was significantly lower than all other treatment types in the year post-treatment. Both CMRs and SMRs were significantly higher in-treatment than post-treatment. Conclusion Better understanding of factors contributing to elevated mortality risk for clients engaged in, and following treatment, is needed to ensure that treatment systems provide optimal outcomes during and after treatment. 2017 Journal Article http://hdl.handle.net/20.500.11937/57697 10.1016/j.jsat.2017.09.001 restricted |
| spellingShingle | Lloyd, B. Zahnow, R. Barratt, Monica Best, D. Lubman, D. Ferris, J. Exploring mortality among drug treatment clients: The relationship between treatment type and mortality |
| title | Exploring mortality among drug treatment clients: The relationship between treatment type and mortality |
| title_full | Exploring mortality among drug treatment clients: The relationship between treatment type and mortality |
| title_fullStr | Exploring mortality among drug treatment clients: The relationship between treatment type and mortality |
| title_full_unstemmed | Exploring mortality among drug treatment clients: The relationship between treatment type and mortality |
| title_short | Exploring mortality among drug treatment clients: The relationship between treatment type and mortality |
| title_sort | exploring mortality among drug treatment clients: the relationship between treatment type and mortality |
| url | http://hdl.handle.net/20.500.11937/57697 |